Company / Interest Expense
10x Genomics, Inc. Interest Expense History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$33.0K
FY2023
5-year range
$33.0K / $3.1M
FY2019-FY2023
Trend
-98.0%
vs FY2022
Sector context
#44 of 43
Health Care
What the data says
Among 43 Health Care companies, 10x Genomics, Inc. is in the top -2% for interest expense. Interest Expense has fluctuated over the past 7 years, ranging from $33,000 in FY2023 to $3M in FY2021.
Based on SEC 10-K filings.
$33,000 in FY2023 with a 5-year CAGR of -57.6%.
Improved from $3M to $33,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -73.0%
- 5-Year CAGR
- -57.6%
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 43This company $33.0K Sector average $324.8M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -57.6%, indicating a declining trend.
- In FY2023, interest expense decreased 98.0% year-over-year.
- Ranks #44 out of 43 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $33.0K | -98.0% |
| FY2022 | $1.7M | -45.4% |
| FY2021 | $3.1M | +83.1% |
| FY2020 | $1.7M | -45.4% |
| FY2019 | $3.1M | +27.8% |
| FY2018 | $2.4M | +197.0% |
| FY2017 | $811.0K | - |
As of FY2023 · SEC 10-K · Updated Jul 1, 2026